Correction to “A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT2B Inverse Agonist with Preclinical Efficacy for Psychoses”

Ítems similars

• A Novel Aminotetralin-Type Serotonin (5-HT) (2C) Receptor-Specific Agonist and 5-HT(2A) Competitive Antagonist/5-HT(2B) Inverse Agonist with Preclinical Efficacy for Psychoses
  per: Canal, Clinton E., et al.
  Publicat: (2014)
• (1R, 3S)-(−)-Trans-PAT: A novel full-efficacy serotonin 5-HT(2C) receptor agonist with 5-HT(2A) and 5-HT(2B) receptor inverse agonist/antagonist activity
  per: Booth, Raymond G., et al.
  Publicat: (2009)
• Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment
  per: Herrick-Davis, Katharine, et al.
  Publicat: (2007)
• Predicted structures and dynamics for agonists and antagonists bound to serotonin 5-HT2B and 5-HT2C receptors
  per: Kim, Soo-Kyung, et al.
  Publicat: (2011)
• S114. EFFICACY OF THE SEROTONIN 5HT-2A INVERSE AGONIST PIMAVANSERIN IN REFRACTORY HALLUCINATIONS AND DELUSIONS THAT FAILED TO RESPOND TO CLOZAPINE OR OTHER ANTIPSYCHOTICS
  per: Nasrallah, Henry, et al.
  Publicat: (2019)